Email this article 
Post-COVID cognitive impairments: targets of neuropsychological rehabilitation
- Authors: Kutkova A.K.1,2,3, Zemlyanykh M.V.1, Voznyuk I.A.2
-
Affiliations:
- Saint Petersburg State Pediatric Medical University
- Academician I.P. Pavlov First St. Petersburg State Medical University
- Dzhanelidze Research Institute of Emergency Medicine
- Issue: Vol 15, No 3 (2024)
- Pages: 77-84
- Section: Clinical psychology
- URL: https://journals.eco-vector.com/pediatr/article/view/642133
- DOI: https://doi.org/10.17816/PED15377-84
- ID: 642133
Cite item
Open Access
Access granted
Abstract
BACKGROUND: At the moment, a large number of scientific studies are devoted to the topic of post-COVID cognitive disorders, as well as to the study of the neurological and psychiatric consequences of COVID-19. However, the issues of describing the cognitive profile that is pathognomonic for a post-COVID patient, as well as the treatment and neurocorrection of emerging disorders are considered extremely rarely.
AIM: The aim of this study is to compile a cognitive profile of a post-COVID patient and identify targets for neuropsychological rehabilitation.
MATERIALS AND METHODS: A complete neuropsychological examination was carried out on 50 patients who had suffered moderate or mild COVID-19 no more than six months ago from the time of research. Used: MoCA test, clock drawing test, verbal association technique, FAB, G. Head test, test for understanding comparative constructions, “barrel and box” test, symbol-numeric coding test, asthenia rating scale (MFI-20), Hospital scale anxiety and depression.
RESULTS: According to the results of screening scales, patients scored borderline between normal and mild (subjective) cognitive decline. No impairments in operational auditory-verbal and visual memory were detected. Low performance in the symbolic-numeric coding technique was revealed, combined with a deterioration in the understanding of logical-grammatical structures. These same scales have a direct correlation with the general level of cognitive integrity. High rates of anxiety and asthenia and low rates of depression were revealed.
CONCLUSIONS: This cohort of patients was found to have mild cognitive deficits. A decrease in neurodynamic parameters and a violation of quasi-spatial concepts come to the fore. There are high rates of anxiety and asthenia with the leading mental component of asthenia, against the background of preserved motivation and low rates of depression. The targets of neurocorrection for these patients are: stability of attention, fluency of speech, speed of thinking, quasi-spatial concepts.
Full Text
About the authors
Anna K. Kutkova
Saint Petersburg State Pediatric Medical University; Academician I.P. Pavlov First St. Petersburg State Medical University; Dzhanelidze Research Institute of Emergency Medicine
Author for correspondence.
Email: kutkova.nura@yandex.ru
ORCID iD: 0009-0001-5825-9686
SPIN-code: 4595-7455
Postgraduate student, Psychosomatics and Psychotherapy Department Medical psychologist, Saint Petersburg State Pediatric Medical University, Ministry of Healthcare of the Russian Federation; Medical psychologist, Academician I.P. Pavlov First St. Petersburg State Medical University, Ministry of Healthcare of the Russian Federation; Medical psychologist, Dzhanelidze Research Institute of Emergency Medicine
Russian Federation, Saint Petersburg; Saint Petersburg; Saint PetersburgMarina V. Zemlyanykh
Saint Petersburg State Pediatric Medical University
Email: mvz6@mail.ru
SPIN-code: 9576-8022
MD, PhD, Associate Professor of the Department of Psychosomatics and Psychotherapy
Russian Federation, Saint PetersburgIgor A. Voznyuk
Academician I.P. Pavlov First St. Petersburg State Medical University
Email: voznjouk@yandex.ru
ORCID iD: 0000-0002-0340-4110
SPIN-code: 3340-2897
MD, Dr. Sci. (Medicine), Professor of the Department of Neurology
Russian Federation, Saint PetersburgReferences
- Balashova EYu, Kovyazina MS. Neuropsychological diagnostics in questions and answers. Moscow: Genezis; 2022. 240 p. (In Russ.)
- Wasserman LI, Dorofeeva SA, Meerson YuA. Methods of neuropsychological diagnostics: A practical guide. Saint Petersburg: Stroylespechat; 1997. 400 p. (In Russ.)
- Golovacheva VA, Tabeeva GR, Kuznetsov IV. Сognitive impairment in COVID-19: associations, pathogenesis and treatment questions. Neurology, Neuropsychiatry, Psychosomatics. 2021;13(2): 123–129. EDN: ZYCCMG doi: 10.14412/2074-2711-2021-2-123-129
- Gusev EI, Bogolepova AN. Cognitive disorders in cerebrovascular diseases. Moscow: MEDpress-Inform; 2013. 176 p. (In Russ.)
- Levin OS. Algorithms of diagnostics and treatment of dementia. Moscow: MEDpress-Inform; 2018. 192 c. (In Russ.)
- Levin OS. Diagnostics and treatment of cognitive disorders and dementia in clinical practice. Moscow: MEDpress-Inform; 2019. 448 c. (In Russ.)
- Lobzin VYu, Litvinenko IV, Pushkaryov VA. Cognitive disorders in COVID-19 survivors: «fog in the head» or debut of neurodegeneration? Safety Bulletin of the Society for Parkinson’s Disease and Disorders Statistics. 2022;(2):138–140. (In Russ.)
- Nekrasova YuYu, Gorshkov KM, Kolesov DV, et al. Neurocognitive impairments in post-COVID patients: pathogenesis and rehabilitation methods. Trudnyi Patsient. 2021;19(6):8–17. EDN: OUQIPR
- Preobrazhenskaya IS. COVID-associated cognitive impairments: A review. Consilium Medicum. 2022;24(2):96–102. EDN: IMWYLI doi: 10.26442/20751753.2022.2.201512
- Taboada M, Moreno E, Cariñena A, et al. Quality of life, functional status, and persistent symptoms after intensive care of COVID-19 patients. Br J Anaesth. 2021;126(3):e110–e113. doi: 10.1016/j.bja.2020.12.007
- Tenforde MW, Kim SS, Lindsell CJ, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network — United States, march–june 2020. MMWR Morb Mortal Wkly Rep. 2020;69(30):993–998. doi: 10.15585/mmwr.mm6930e1
Supplementary files
